Study Shows Half Of Men In General Population Infected With HPV
2/28/2011
An Article published Online First by The Lancet shows that approximately 50% of men from a sample of the general population are infected with the human papillomavirus (HPV). Per year, 6% of men will acquire a new HPV 16 infection, the virus most well known for causing cervical cancer in women and also causing cancers in men...
High-Cost Hospitals Do Not Appear To Have Better Survival Rates For Sepsis Patients
2/28/2011
Increased hospital spending at high-cost hospitals does not appear to be associated with better short-term survival rates for patients with sepsis, according to a report in the February 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals...
Teens May Be Banned From Tanning Beds
2/28/2011
Tanning beds are a big pastime for up and coming teens as they prepare for Spring break, pool parties and outdoor fun. However, the American Academy of Pediatrics (AAP) thinks teens should be banned from tanning beds due to serious risk of melanoma, the deadliest form of skin cancer. About 8,700 people died of melanoma last year...
Phase 2 Lymphoseek(R) (Tilmanocept) Data Published Online In Annals Of Surgical Oncology
2/28/2011
Neoprobe Corporation (NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced that results from a Phase II study of Lymphoseek® (Tilmanocept) have been published online in the Annals of Surgical Oncology and demonstrate the tracing agent's ability to identify tumor-draining lymph nodes in breast cancer and melanoma patients...
Radio-Guided Surgery A Safe And Simple Way To Remove Potentially Cancerous Nodules In The Lung
2/28/2011
Using tiny spheres of radioactive liquid to guide surgeons as they remove potentially cancerous material in the lungs is safe and more effective than other techniques, Italian researchers report at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), 24-26 February 2011, Lugano, Switzerland...
Erlotinib Effective And With Fewer Side-Effects After First-Line Treatment
2/28/2011
The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show...
Scientists Discover Cause Of Rare Skin Cancer That Heals Itself
2/28/2011
Cancer Research UK scientists have discovered the gene behind a rare skin cancer which grows rapidly for a few weeks before healing spontaneously, according to research published in Nature Genetics...
Aggressive Type Of Lung Cancer In Never-Smokers Identified By Quick, Easy Test
2/28/2011
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found...
Oncogene AEG-1 Strongly Predicts Response To Erlotinib Treatment In EGFR-Mutant Lung Cancer
2/28/2011
Spanish researchers have identified a gene whose expression level strongly predicts how well certain lung cancer patients will respond to treatment with the drug erlotinib. Dr Rafael Rosell and colleagues reported their findings at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), 24-26 February 2011 in Lugano, Switzerland...
Bone Drug Zoledronic Acid May Help Prevent Spread Of Early Lung Cancer
2/28/2011
A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers have found...